Hypertension. Hypertensive diseases
Conditions
Interventions
Intervention 1: intervention group 1: 10 g of powder flaxseed daily after meals for 12 weeks. Intervention 2: intervention group 2: 30 grams of powdered flaxseed daily after meals for 12 weeks. Interv
Treatment - Drugs
intervention group 1: 10 g of powder flaxseed daily after meals for 12 weeks
intervention group 2: 30 grams of powdered flaxseed daily after meals for 12 weeks
Control group: daily 10 grams of wheat flour for 12 weeks
Sponsors
Vice President of Research Lorestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age range 35 to 70 years;The risk of prehypertension 120/80 until the 139/89, mild hypertension 140/90 until the 159/99 and the average blood pressure of 160/100 until the 179/109, according to psychiatrists; Not having any allergy to flaxseed and its products; The lack of psychiatric disorders; Access patients or caregivers to phone; No pain and acute diseases; Access to the patient three months after entering the study; no use of angiotensin converting enzyme inhibitors such as captopril; Not taking digoxin; No history of obstructive pulmonary disease and inflammatory bowel, celiac disease, stomach ulcers, gastrointestinal bleeding, large, kidney failure Exclusion criteria: Unwillingness of patients or caregivers to continue research ; Diarrhea,inflammatory bowel disease, bowel obstruction, or allergy or need any kind of surgery during the course of the study; Having regular exercise and vigorous; The patient died; Out of reach of the patient's illness or change a contact number and responding to telephone follow; Pregnancy and lactation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before and six and twelve weeks after the intervention. Method of measurement: Mark Hine sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Before and six and twelve weeks after the intervention. Method of measurement: Through dividing body weight (kg) by height (m*2).;Blood cholesterol level. Timepoint: Before and six and twelve weeks after the intervention. Method of measurement: Laboratory tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMassome Yarahmadi
Lorestan University of Medical Sciences
Outcome results
None listed